相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Weaker protection against tuberculosis in BCG-vaccinated male 129 S2 mice compared to females
Natalie E. Nieuwenhuizen et al.
VACCINE (2021)
Disputed rpoB Mutations in Mycobacterium tuberculosis and Tuberculosis Treatment Outcomes
Wan-Hsuan Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Interpretation of Discordant Rifampicin Susceptibility Test Results Obtained Using GeneXpert vs Phenotypic Drug Susceptibility Testing
Fengmin Huo et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review
Thi Ngoc Anh Nguyen et al.
FRONTIERS IN MICROBIOLOGY (2019)
A 10-Year Comparative Analysis Shows that Increasing Prevalence of Rifampin-Resistant Mycobacterium tuberculosis in China Is Associated with the Transmission of Strains Harboring Compensatory Mutations
Fengmin Huo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Role of Disputed Mutations in the rpoB Gene in Interpretation of Automated Liquid MGIT Culture Results for Rifampin Susceptibility Testing of Mycobacterium tuberculosis
Paolo Miotto et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
Wei Jing et al.
FRONTIERS IN MICROBIOLOGY (2017)
Comparison of Different Drug Susceptibility Test Methods To Detect Rifampin Heteroresistance in Mycobacterium tuberculosis
Zhijian Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Optimization of the Rifampin Dosage to Improve the Therapeutic Efficacy in Tuberculosis Treatment Using a Murine Model
Jurriaan E. M. de Steenwinkel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Study of the Rifampin Monoresistance Mechanism in Mycobacterium tuberculosis
Yu Pang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations
Leen Rigouts et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test
Stephen D. Lawn et al.
LANCET INFECTIOUS DISEASES (2013)
Rifampicin Resistance: Fitness Costs and the Significance of Compensatory Evolution
Diarmaid Hughes et al.
ANTIBIOTICS-BASEL (2013)
The Beginning of the rpoB Gene in Addition to the Rifampin Resistance Determination Region Might Be Needed for Identifying Rifampin/Rifabutin Cross-Resistance in Multidrug-Resistant Mycobacterium tuberculosis Isolates from Southern China
Yaoju Tan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Direct Drug Susceptibility Testing of Mycobacterium tuberculosis for Rapid Detection of Multidrug Resistance Using the Bactec MGIT 960 System: a Multicenter Study
Salman Siddiqi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Comparison of Three Statistical Methods for Establishing Tentative Wild-Type Population and Epidemiological Cutoff Values for Echinocandins, Amphotericin B, Flucytosine, and Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method
Emilia Canton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
MDR Tuberculosis - Critical Steps for Prevention and Control
Eva Nathanson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis
DH Mariam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility
E Banfi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis
P Bemer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Evaluation of BACTEC mycobacteria growth indicator tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis
F Ardito et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
分享论文
